TNO-001

N/A

Report date: 2025/01/26 16:21:29

Base Information

Drug NameTNO-001

Drug Alias Nameadeno-associated virus-mediated gene therapy (Tenaya Therapeutics)cardiac reprogramming therapeutic cocktail (Tenaya Therapeutics)TNO-001 (Tenaya Therapeutics)in vivo reprogramming of cardiac fibroblast into cardiomyocytes (Tenaya Therapeutics)AAV:GFP +[6]

ClassificationBiologics

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMyocardial Infarction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTenaya Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesTenaya Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMyocardial Infarction

Inactive IndicationsN/A

Other Information

ATC CodeN/A